However, these findings were contrary to the report by Liebhardt et al (Liebhardt et al., 2010), which concluded that breast cancer patients with smaller tumor size (T1) had a significantly higher level of annexin V+ MPs than controls, and also MP levels did not differ between T2 patients and controls. The gene discussed is ANXA5; the disease is breast carcinoma.